Abstract
AbstractSerine 129 and, to a lesser extent, serine 87 can appear phosphorylated in the intrinsically disordered protein humanα-synuclein (AS), a key player in Parkinson’s disease, where it accumulates in proteinaceous aggregates. Intriguingly, both phosphorylations are located in a highly negative potential region of the protein. Here we used molecular simulation to provide insight in the selective phosphorylation by polo-like kinase 2 (PLK2), in both monomeric and fibrillar forms of AS. We suggest that phosphorylation does not impact on the structural determinants of the physiological AS conformational ensemble, as the phosphate group is mostly solvated. Our findings are consistent with experimental data on the non-acetylated, non-physiological form of the protein. The phosphate groups of pAS may be solvated also in the aggregated form.
Publisher
Cold Spring Harbor Laboratory
Reference91 articles.
1. Ageing as a risk factor for neu-rodegenerative disease;Nature Reviews Neurology,2019
2. The burden of Parkinson’s disease: a worldwide perspective;The Lancet,2018
3. Alpha-synuclein and Parkinson’s disease;Cellular and Molecular Life Sciences CMLS,2000
4. Aggregation of alphasynuclein in Lewy bodies of sporadic Parkinson’s disease and dementia with Lewy bodies;The American journal of pathology,1998
5. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.